These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10363743)

  • 21. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
    Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
    J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy.
    Benatar D; Hall V; Reddy S; Gheorghiade M
    Am J Ther; 1998 Jan; 5(1):25-32. PubMed ID: 10099034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure.
    Böhm M; Deutsch HJ; Hartmann D; Rosée KL; Stäblein A
    J Am Coll Cardiol; 1997 Oct; 30(4):992-6. PubMed ID: 9316529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of repeated echocardiographic evaluation in patients with idiopathic dilated cardiomyopathy during treatment with metoprolol or captopril.
    Jansson K; Dahlström U; Karlberg KE; Karlsson E; Nyquist O; Nylander E
    Scand Cardiovasc J; 2000 Jun; 34(3):293-300. PubMed ID: 10935777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors and beta-blockers in long-term treatment of dilated cardiomyopathy.
    Regitz-Zagrosek V; Leuchs B; Krülls-Münch J; Fleck E
    Am Heart J; 1995 Apr; 129(4):754-61. PubMed ID: 7900628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of xinshuai mistura on plasma angiotensin II, atrial natriuretic peptide and N terminal pro-brain natriuretic peptide in patients with heart failure].
    Dai M; Wen QX; He JR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Oct; 26(10):888-91. PubMed ID: 17121038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normotensive sodium loading in conscious dogs: regulation of renin secretion during beta-receptor blockade.
    Bie P; Mølstrøm S; Wamberg S
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R428-35. PubMed ID: 19073902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure.
    Yasumura Y; Miyatake K; Okamoto H; Miyauchi T; Kawana M; Tsutamoto T; Kitakaze M; Matsubara H; Takaoka H; Anzai T; Himeno H; Yokoyama H; Yokoya K; Shintani U; Hashimoto K; Koretsune Y; Nakamura Y; Imai K; Maruyama S; Masaoka Y; Sekiya M; Shiraki T; Shinohara H; Ozono K; Matsuoka T; Miyao Y; Nomura F
    Circ J; 2004 Apr; 68(4):361-6. PubMed ID: 15056835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor.
    Kinugawa T; Ogino K; Kato M; Furuse Y; Shimoyama M; Mori M; Endo A; Kato T; Omodani H; Osaki S; Miyakoda H; Hisatome I; Shigemasa C
    Gen Pharmacol; 1998 Jul; 31(1):93-9. PubMed ID: 9595286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Captopril and hypertensive cardiopathy : therapeutic effects and hormonal changes].
    Palazzuoli V; Mondillo S; Galli M; Kristodhullu S; Faglia S; D'Aprile N; Martorelli T
    Cardiologia; 1990 Jun; 35(6):489-93. PubMed ID: 2150343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(9):61-71. PubMed ID: 17076227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure.
    Dutka DP; Olivotto I; Ward S; Nihoyannopoulos P; al-Subaili M; Oakley CM; Impallomeni M; Cleland JG
    Eur Heart J; 1995 Sep; 16(9):1223-30. PubMed ID: 8582385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages.
    Pacher R; Globits S; Bergler-Klein J; Teufelsbauer H; Wutte M; Baumgartner W; Ogris E; Glogar D
    Eur Heart J; 1993 Feb; 14(2):273-8. PubMed ID: 8449205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altering angiotensin levels by administration of captopril or indomethacin, or by angiotensin infusion, contributes to an understanding of atrial natriuretic peptide regulation in man.
    Klemm SA; Gordon RD; Tunny TJ; Hamlet SM
    Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):349-55. PubMed ID: 2978745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].
    Radzevich AE; Ditiatkov AE; Tikhonov VA
    Probl Tuberk; 2001; (5):16-9. PubMed ID: 11588951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in lymphocyte beta-receptor density in patients with heart failure before and after metoprolol or captopril administration].
    Qin S; Ma C
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Jun; 20(3):149-51, 195. PubMed ID: 1337738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.